0 0 -0.000613685179503054 -0.000613685179503054 0.0269407793801779 0.0342743172752377 0.0460263884627186 0.0450444921755138
Sign Up Today X
Thanks for submitting the form.
Stockreport

U.S. company directors compensated more than ever, but now risk backlash [Reuters]

Regeneron Pharmaceuticals, Inc. (REGN)  More Company Research Source: Reuters
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
U.S. company directors compensated more than ever, but now risk backlash - Reuters 7 Min Read BOSTON (Reuters) - It’s nice work if you can get it. The average annual compensation for non-executive directors at S&P 500 companies rose 2 percent to $304,856 last year, topping $300,000 for the first time and 43 percent higher than it was 10 years ago, according to a new report released by executive headhunters Spencer Stuart. But thanks largely to stock grants some earned a lot more than that. Directors at biotechnology company Regeneron Pharmaceuticals Inc ( REGN.O ) received, on average, $1.2 million in compensation last year. That figure does not include the more than $6 million received by Regeneron’s independent chairman, company disclosures show. And the non-executive directors of Wall Street powerhouse Goldman Sachs Group Inc ( GS.N ) made $599,279 on average in 2018, the highest for any financial company in the S&P. That was, though, down from $604,837 in 2017. The investment [Read more]
IMPACT SNAPSHOT EVENT TIME: REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
REGN alerts
from News Quantified
REGN
NEWS
REGN
Earnings
REGN
Analyst Actions
REGN
SEC Filings
Stockreport

U.S. company directors compensated more than ever, but now risk backlash [Reuters]

Regeneron Pharmaceuticals, Inc.  (REGN) 
More Company Research Source: Reuters
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
U.S. company directors compensated more than ever, but now risk backlash - Reuters 7 Min Read BOSTON (Reuters) - It’s nice work if you can get it. The average annual compensation for non-executive directors at S&P 500 companies rose 2 percent to $304,856 last year, topping $300,000 for the first time and 43 percent higher than it was 10 years ago, according to a new report released by executive headhunters Spencer Stuart. But thanks largely to stock grants some earned a lot more than that. Directors at biotechnology company Regeneron Pharmaceuticals Inc ( REGN.O ) received, on average, $1.2 million in compensation last year. That figure does not include the more than $6 million received by Regeneron’s independent chairman, company disclosures show. And the non-executive directors of Wall Street powerhouse Goldman Sachs Group Inc ( GS.N ) made $599,279 on average in 2018, the highest for any financial company in the S&P. That was, though, down from $604,837 in 2017. The investment [Read more]
IMPACT SNAPSHOT
EVENT TIME:
REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS